"The guest argued that UFP Technologies benefits from a valuation re-rating as it transitions into a specialized healthcare outsource manufacturer alongside accretive bolt-on acquisitions."

"Contrary to the perception that microcaps are low-quality widget makers, durable competitive moats and high-caliber management teams exist in the asset class, offering long-term compounding potential."